Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.59 USD | +8.36% | +36.03% | +552.38% |
Apr. 11 | Sector Update: Health Care Stocks Decline Thursday Afternoon | MT |
Apr. 11 | Candel Therapeutics Shares Rise After FDA Orphan Drug Designation for Potential Pancreatic Cancer Drug | MT |
Chart calendar Candel Therapeutics, Inc.
Upcoming events on Candel Therapeutics, Inc.
Past events on Candel Therapeutics, Inc.
2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No - LB263 |
2024-03-28 08:05 am | Q4 2023 Earnings Release |
2024-03-27 | Glioblastoma Drug Development Summit |
2023-11-09 08:00 am | Q3 2023 Earnings Release |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number :1096 |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number :1348 |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number :653 |
2023-09-11 03:00 pm | H.C. Wainwright Global Investment Conference |
2023-08-10 11:30 am | Canaccord Genuity Growth Conference |
2023-08-10 08:00 am | Q2 2023 Earnings Release |
2023-06-28 10:00 am | Annual General Meeting |
2023-06-07 04:00 pm | Jefferies Global Healthcare Conference |
2023-06-04 09:00 am | American Society of Clinical Oncology Conference - Charu Aggarwal |
2023-05-19 11:00 am | American Society of Gene Cell Therapy Meeting - Francesca Barone |
2023-05-11 08:00 am | Q1 2023 Earnings Release |
2023-03-30 08:00 am | Q4 2022 Earnings Release |
2023-02-08 03:20 pm | Guggenheim Oncology Conference |
2023-01-19 11:30 am | B. Riley Securities Oncology Conference |
2022-12-06 11:00 am | R&D Day |
2022-11-18 05:30 pm | Society for Neuro-Oncology Meeting |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,13 0,03 278.79% | 0,13 0,11 15.39% | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | -25,5 -24,0 -6.44% | -33,9 -37,1 8.58% | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -25,7 -26,4 2.59% | -34,7 -36,4 4.57% | -38,4 -37,3 -2.92% | -46,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -36,1 -47,5 23.95% | -18,8 -21,8 13.59% | -37,9 -31,6 -20.06% | -41,6 |
Net income Million USD | Released Forecast Spread | -36,1 -40,7 11.24% | -18,8 -21,8 13.59% | -37,9 -31,6 -20.06% | -41,6 |
EPS USD | Released Forecast Spread | -1,91 -2,14 10.9% | -0,65 -0,70 7.75% | -1,31 -1,09 -20.18% | -0,91 |
Announcement Date | 29/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,03 0,02 106.67% | 0,03 0,02 100% | 0,03 0,00 - | 0,03 0,01 200.1% | 0,03 0,01 121.43% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
EBITDA Million USD | Released Forecast Spread | -7,56 -7,45 -1.55% | -8,82 -7,64 -15.52% | -8,57 -5,76 -48.61% | -8,68 -8,19 -5.89% | -7,88 | ||||
EBIT Million USD | Released Forecast Spread | -7,74 -8,24 6.01% | -8,99 -10,9 17.84% | -8,75 -13,8 36.53% | -8,88 -11,7 24.23% | -8,10 -11,7 30.54% | -9,63 -10,0 3.67% | -9,58 -11,1 13.31% | -8,86 -9,90 10.49% | -10,3 -9,20 -12.15% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,08 -4,80 -5.9% | -9,61 -6,60 -45.67% | -8,44 -5,40 -56.2% | -11,1 -4,70 -136.06% | |||||
Net income Million USD | Released Forecast Spread | 1,60 -9,00 117.73% | -0,87 -14,2 93.85% | -4,15 -16,0 74.07% | -8,69 -16,0 45.7% | -5,08 -4,80 -5.9% | -9,61 -6,60 -45.67% | -8,44 -5,40 -56.2% | -11,1 -4,70 -136.06% | |
EPS USD | Released Forecast Spread | 0,51 -0,35 244.58% | -0,03 -0,34 91.1% | -0,14 -0,45 69.12% | -0,30 -0,36 16.48% | -0,17 -0,31 44.33% | -0,30 -0,35 14.29% | -0,33 -0,30 -10% | -0,29 -0,19 -52.63% | -0,38 -0,16 -137.5% |
Announcement Date | 29/03/22 | 12/05/22 | 05/08/22 | 10/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 |
Past sector events for Candel Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CADL Stock
- Calendar Candel Therapeutics, Inc.